Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 666 of 1,261
  1. US 9486518

    Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  2. US 9487485

    Method for producing sulfonyl chloride compound

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  3. US 9487514

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  4. US 9487526

    Quinoxaline derivatives as GPR6 modulators

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  5. US 9487590

    Activatable antibodies that bind interleukin-6 receptor and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  6. US 9487522

    SSH-2 (slingshot-2) inhibitors and methods for making and using them

    The Regents of the University of California · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  7. US 9487786

    Immunosuppression compound and treatment method

    Sarepta Therapeutics, Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  8. US 9487780

    Antisense compounds targeting genes associated with fibronectin

    Ionis Pharmaceuticals, Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  9. US 9487753

    Compositions of adult disc stem cells and methods for the treatment of degenerative disc disease

    DiscGenics, Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  10. US 9487579

    Methods and compositions for modulation of blood-neural barrier

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  11. US 9487575

    Compositions and methods for treatment of gynecologic cancers

    The Regents of the University of California · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  12. US 9487573

    Murine anti-NY-ESO-1 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  13. US 9487556

    Polyconjugates for delivery of RNAi triggers to tumor cells in vivo

    Arrowhead Pharmaceuticals, Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  14. US 9487563

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  15. US 9487551

    Small molecule compounds that control mammal-pathogenic nematodes

    The Regents of the University of California · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  16. US 9487509

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  17. US 9487508

    SGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  18. US 9487511

    Cyclopropanamine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  19. US 9487473

    Oligomer-amino acid conjugates

    Nektar Therapeutics · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  20. US 9487477

    Crystalline phase of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine

    QUANTUM GENOMICS · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  21. US 9486540

    Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders

    Northwestern University · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  22. US 9487493

    Use of a PPAR-delta agonist for treating muscle atrophy

    VTV THERAPEUTICS LLC · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  23. US 9486531

    Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system

    Indivior UK Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  24. US 9486523

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    XBIOTECH INC. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.